On The Pen: The Weekly Dose cover art

On The Pen: The Weekly Dose

By: Dave Knapp Man On The Mounjaro
Listen for free

  • Summary

  • Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
    © 2024 On The Pen: The Weekly Dose
    Show More Show Less
Episodes
  • On The Pen: The Weekly Dose 6.4.24

    On The Pen: The Weekly Dose 6.4.24
    Jun 4 2024

    Send us a Text Message.

    https://ro.co/weight-loss/supply-tracker
    https://www.youtube.com/watch?v=mL_krAas70k

    Novo Nordisk Advertising:

    • Novo Nordisk launches new advertising campaign "The Power of Wegovy"
    • This advertisement includes the new indication for reduction of cardiovascular risk
    • For 2023, the #5 advertising spend for a drug was Rybelsus at $191 million. The #6 advertising spend was Ozempic at $187.4 million (increase of 6% from 2022). More than 40% of the 2023 ad spend for Ozempic went to online video platforms (i.e. social media like youtube)
    • Link: https://www.youtube.com/watch?v=dhretLXYkZ4

    Structure Therapeutics GSBR-1290

    • GSBR-1290 is a small molecule GLP-1 pill
    • In a 12-week phase 2 clinical study, a tablet formulation of GSBR-1290 had a weight-loss of 6.9%. This is comparable to Eli Lilly's phase 2 results for olforglipron
    • At Week 12, 67% of GSBR-1290 treated participants achieved ≥6% weight loss and 33% achieved ≥ 10% weight loss, compared to 0% for placebo
    • Also developing next generation combination GLP-1 candidates together with GIP, amylin, glucagon and apelin oral small molecules
    • Link (Madison Muller): https://www.bloomberg.com/news/articles/2024-06-03/structure-reports-early-oral-weight-loss-drug-data-adding-allure


    Elon musk tweet:

    • Elon Musk tweeted: Just make a lot of Ozempic/Mounjaro. It’s not inherently expensive. The health benefits of reducing obesity far exceed the downside of GLP-1 inhibitors. We evolved under starving conditions and now make food that is plentiful and delicious. Whether that food is “processed” does matter, but is not a game changer
    • This tweet has currently been seen 325,500 times

    Shanghai Stem Cell Type 2 Diabetes Treatment
    https://www.scmp.com/news/china/science/article/3263878/chinese-scientists-report-world-first-they-cure-patients-diabetes-cell-therapy

    Support the Show.

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    #Zepbound #releasethevials #mounjaro

    📲 Contact Me: MounjaroMan@gmail.com

    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.

    Show More Show Less
    17 mins
  • OTP EPS 68: Ro CEO Zach Reitano Talks GLP-1 Supply Tracker

    OTP EPS 68: Ro CEO Zach Reitano Talks GLP-1 Supply Tracker
    May 31 2024

    Send us a Text Message.

    Zachariah Reitano is the founder of Ro, a telehealth company that has a vision of giving consumers more power over their health, he joins #OnThePen to talk all things #mounjaro #zepbound #wegovy #ozempic

    Reitano is the founder of Ro, a telehealth company that has a vision of giving consumers more power over their health.

    https://ro.co/weight-loss/supply-tracker/

    Support the Show.

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    #Zepbound #releasethevials #mounjaro

    📲 Contact Me: MounjaroMan@gmail.com

    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.

    Show More Show Less
    1 hr and 5 mins
  • On The Pen: The Weekly Dose 5.28.24

    On The Pen: The Weekly Dose 5.28.24
    May 28 2024

    Send us a Text Message.

    On The Pen News: https://www.onthepen.com/blog

    SHOW NOTES:
    Ozempic study in New England Journal of Medicine:
    Link: https://www.bloomberg.com/news/articles/2024-05-24/novo-s-ozempic-slashes-risk-of-death-in-kidney-disease-study

    Compounding (tiktok video)
    Link: https://www.abc.net.au/news/2024-05-22/compound-pharmacies-banned-weight-loss-drugs-replica-ozempic/103861108

    Zealand Pharma:
    Link: https://www.biospace.com/article/zealand-touts-phase-i-results-for-glp-1-glp-2-candidate-despite-modest-weight-loss-/

    Inhaled GLP-1 medications
    Link: https://www.biostock.se/en/2024/05/iconovo-initiates-development-of-inhaled-obesity-treatment/

    Oral version of tirzepatide (tiktok video):
    Link: https://ca.finance.yahoo.com/news/lexaria-awards-contract-third-glp-130500555.html

    Mounjaro approved for China (tiktok video):
    Link: https://www.bloomberg.com/news/articles/2024-05-21/china-clears-eli-lilly-s-weight-loss-drug-tirzepatide-only-for-diabetes

    Eli Lilly announces capacity increase (tiktok video)
    Link: https://investor.lilly.com/news-releases/news-release-details/lilly-increases-manufacturing-investment-9-billion-newest

    GLP-1 usage by young people:
    From 2020 to 2023, the number of U.S. adolescents and young

    Support the Show.

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    #Zepbound #releasethevials #mounjaro

    📲 Contact Me: MounjaroMan@gmail.com

    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.

    Show More Show Less
    19 mins
Business & Careers Physical Illness & Disease Hygiene & Healthy Living Politics & Government
Show More Show Less

What listeners say about On The Pen: The Weekly Dose

Average customer ratings
Overall
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Performance
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Story
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
Sort by:
Filter by:
  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars
Profile Image for Nicola Vaughan

Extremely Informative

As a current U.K. based Mounjaro user for PCOS concerns, I find these podcasts highly informative - guests highly knowledgeable and the approach from the podcasters clear. I have become increasingly more confident regarding side effects, studies, medical potential of glp1 medications and ‘seen’ by the podcasters with their approach regarding to discussions on ‘food noise’ since listening. Excellently done. 10/10 would recommend.

Report this

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!